Breast cancer gene-expression blood test
DiaGenic and Applied Biosystems have launched BCtect, a blood-based test for early detection of breast cancer. The test searches for a unique gene expression signature using a custom TaqMan array.
The test uses peripheral blood rather than tissue from the actual breast, providing a less invasive method of testing. It is also not affected by ethnic variation or the menopausal state of the patient, allowing for widespread use to diagnose breast cancer at an early stage.
The TaqMan Array consists of 96 TaqMan gene expression assays pre-loaded multiple times on a 384-well microfluidic card. These 384 simultaneous, real-time PCR reactions are performed without the need to use liquid-handling robots or multichannel pipettors. The array is run on the 7900HT Fast Real-time PCR System by Labindia.
Phone: 03 9730 8600
Beckman Coulter Life Sciences Basophil Activation Test (BAT) for food allergy research
Beckman Coulter Life Sciences introduces its next-generation Basophil Activation Test (BAT) to...
TopoGEN Topoisomerase Assay Kits
TopoGEN provides innovative reagents and kits for topoisomerase research and mechanism-based drug...
Alamar Biosciences NULISAseq Mouse Panel 120 for protein biomarker analysis
The multiplex panel encompasses a wide selection of proteins essential for studying key...
